Please login to the form below

Not currently logged in
Email:
Password:

AZD0914

This page shows the latest AZD0914 news and features for those working in and with pharma, biotech and healthcare.

Cubist antibiotic to get priority review in US

Cubist antibiotic to get priority review in US

It is the second boost for new antibiotics in the US this month after the FDA's decision to grant fast track status to AstraZeneca's AZD0914 for the sexually transmitted

Latest news

  • FDA fast-tracks new AstraZeneca antibiotic FDA fast-tracks new AstraZeneca antibiotic

    FDA. AZD0914 has shown promise as a treatment for the sexually transmitted infection (STI) uncomplicated gonorrhoea, which, like other infectious diseases, is growing increasingly resistant to existing antibiotics. ... AZD0914 is also classed as a

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics